Related Experiment Video
Updated: May 7, 2026

Models of Bone Metastasis
Published on: September 4, 2012
Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancers
Thomas E Kruger1, Andrew H Miller1, Andrew K Godwin2
1Harrington Laboratory for Molecular Orthopedics, Department of Orthopedic Surgery, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Abstract:
The mechanisms underlying malignant cell metastasis to secondary sites such as bone are complex and no doubt multifactorial. Members of the small integrin-binding ligand N-linked glycoproteins (SIBLINGs) family, particularly bone sialoprotein (BSP) and osteopontin (OPN), exhibit multiple activities known to promote malignant cell proliferation, detachment, invasion, and metastasis of several osteotropic cancers. The expression level of BSP and OPN is elevated in a variety of human cancers, particularly those that metastasize preferentially to the skeleton. Recent studies suggest that the "osteomimicry" of malignant cells is not only conferred by transmembrane receptors bound by BSP and OPN, but includes the "switch" in gene expression repertoire typically expressed in cells of skeletal lineage. Understanding the role of BSP and OPN in tumor progression, altered pathophysiology of bone microenvironment, and tumor metastasis to bone will likely result in development of better diagnostic approaches and therapeutic regimens for osteotropic malignant diseases.
Insights
Bone sialoprotein (BSP) and osteopontin (OPN) promote cancer metastasis to bone. Understanding these small integrin-binding ligand N-linked glycoproteins (SIBLINGs) aids in developing new cancer diagnostics and therapies.
Area of Science:
- Oncology
- Biochemistry
- Cell Biology
Background:
- Malignant cell metastasis to bone is a complex process.
- Small integrin-binding ligand N-linked glycoproteins (SIBLINGs), including bone sialoprotein (BSP) and osteopontin (OPN), are implicated in cancer progression.
- Elevated BSP and OPN expression is observed in cancers that preferentially metastasize to the skeleton.
Purpose of the Study:
- To elucidate the role of BSP and OPN in tumor progression and metastasis to bone.
- To understand how malignant cells mimic skeletal cells ('osteomimicry').
- To explore the contribution of BSP and OPN to the bone microenvironment's altered pathophysiology.
Main Methods:
- Analysis of gene expression profiles in osteotropic cancers.
- Investigation of BSP and OPN interactions with transmembrane receptors.
- Studies on the 'osteomimicry' phenomenon in malignant cells.
Main Results:
- BSP and OPN exhibit pro-metastatic activities, including promoting proliferation, detachment, and invasion.
- Increased expression of BSP and OPN correlates with skeletal metastasis in various human cancers.
- Malignant cells adopt skeletal lineage gene expression patterns, facilitated by BSP and OPN.
Conclusions:
- BSP and OPN play critical roles in promoting tumor metastasis to bone.
- Understanding the osteomimicry mechanism driven by BSP and OPN is key to targeting skeletal metastases.
- Further research into BSP and OPN functions can lead to improved diagnostic and therapeutic strategies for bone-metastatic cancers.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Bone Cells and Tissue
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the periosteum and...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

